Sterling Capital Management LLC Mirum Pharmaceuticals, Inc. Transaction History
Sterling Capital Management LLC
- $7.3 Trillion
- Q4 2024
A detailed history of Sterling Capital Management LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 40 shares of MIRM stock, worth $2,108. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40
Previous 40
-0.0%
Holding current value
$2,108
Previous $1.56 Million
6.03%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$346 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$241 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$171 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$147 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$137 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.94B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...